Lagonero, Rhea May .

HRN: 13-27-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/02/2023
09/08/2023
PO
15ml
Q8H
Intestinal Amoebiasis
Waiting Final Action 
09/02/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/02/2023
09/08/2023
PO
125/5
Q8
Amoebiasis
09/03/2023
CEFTRIAXONE 1G (VIAL)
09/03/2023
09/10/2023
IV
2.3g
OD
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: